Services
A Partner in the firmโs Corporate Department and member of Wigginโs Executive Committee, Evan is dedicated to helping growth-stage companies, publicly held middle-market companies, family offices, high-net-worth individuals, private equity firms, and other clients achieve their business goals.
Evan focuses on corporate finance transactions, mergers and acquisitions, venture capital financing, securities law, licensing arrangements, and general corporate matters, across a broad range of industries that includes software/information technology, life sciences, digital media, financial services, high-tech manufacturing, educational technology, consumer products, and food and beverages. He is known for his ability to quickly grasp complex situations, deliver business-minded legal advice, and help clients surmount obstacles. Over the past few years, Evan has been involved in hundreds of venture capital and M&A transactions with billions of dollars in value.
In addition to handling specific transactions, Evan regularly serves as outside general counsel for privately held companies at various stages of development, ensuring that they are appropriately structured, scalable, and positioned for growth.
An active member of the business and investment community in the heart of the corridor connecting Boston and New York, Evan cultivates a network that includes organizations such as Connecticut Technology Council, BioCT, Angel Investor Forum, ELabNYC, the Entrepreneurship Foundation, ABCT, Angel Capital Association, ClimateHaven, Westchester Biosciences, and the Association for Corporate Growth, as well as academic institutions such as Columbia University, New York University, University of Connecticut, and Yale University.
Evan received his J.D. from the University of Pennsylvania Law School, where he was a senior editor at the Journal of International Economic Law. He received his B.A. in international relations and political science from the University of Pennsylvania.
Education
- University of Pennsylvania Law School (J.D., 2005)
- University of Pennsylvania (B.A., 2001)
Bar Admissions
Awards and Recognitions
Services
News
Services
Publications
Services
Events
Services
Podcasts
Experience
Mergers and Acquisitions
Some of Evanโs experience includes the representation of
- AlloMek Therapeutics, a biotech company focused on drug discovery for the central nervous system, in its sale to Pasithea Therapeutics Corp. (Nasdaq)
- iCleanse, LLC, in its acquisition of ReadyDock, Inc., a manufacturer and developer of chemical-free disinfection devices
- iDevices, LLC, a leading IoT company, in its sale to Hubbell Incorporated (NYSE), an electronic manufacture for the commercial, industrial, utility, and telecommunications markets
- Harman International Industries, Incorporated in its acquisition of Yurbuds, a market leader in sports headphones
- Highway Toll Administration, LLC, a leader in electronic toll collection services and technology, in connection with its sale to Platinum Equity, a private equity firm
- Notable Labs, Inc., a clinical stage therapeutic platform company developing predictive precision medicines, in a reverse merger transaction with VBL Therapeutics (Nasdaq), an Israeli company
- SDG Corporation, a leading provider of cybersecurity services, in connection with a significant strategic investment from Recognize Partners, a private equity firm
Venture Capital Transactions
Some of Evanโs experience includes the representation of
- 6K, Inc. in connection with a $102 million Series D Financing led by Koch Strategic Platforms and including investments from Energy Impact Partners, HG Ventures, Albermale and existing investors
- Boxcar PMJ, as lead investor in Immuneering Corporationโs $20 million Series A financing
- Inbox Health in connection with a $22.5 million Series B Financing led by Ten Coves Capital and including investments from Commerce Ventures, Vertical Venture Partners, Healthy Ventures, Collaborative Fund, Fairview Capital and CT Innovations, among other investors
- IsoPlexis Corporation in connection with raising a $135 million Series D financing, comprised of $85 million in equity securities and a $50 million credit facility, led by Perceptive Advisors and including investments from Ally Bridge Group, BlackRock and Northpond Ventures, among other investors
- Point72 Ventures in connection with its role as an investor in numerous technology businesses
- Rallybio, LLC in connection with a $145 million Series B Financing led by Pivotal bioVenture Partners and including Viking Global Capital, TPG, F-Prime Capital, 5AM Ventures, Canaan Partners and New Leaf Venture Partners, among other investors
- Veradermics Incorporated, in connection with its $75 million Series B financing led by Suvretta Capital Management and included Longitude Capital, Surveyor Capital (a Citadel company), Osage University Partners, PhiFund and JW Childs Associates, among other investors
Other Representative Transactions
- Advised Special Committee of the Board of Directors of a publicly traded life settlements company in connection with a sale of the company
- Representation of numerous life sciences and technology companies in the negotiation of exclusive licenses of respective technologies from universities
- Formation of and preparation of organizational documentation and shareholdersโ agreements for international e-commerce platform
- Representation of NASDAQ listed medical device company in the negotiation of key product development and supply agreement
- Representation of Swedish pharmaceutical company in the negotiation of a collaboration agreement with European university
- Representation of Strategic Venue Partners, an infrastructure development firm backed by Tiger Infrastructure Partners, in the creation of a platform for expanding its wireless infrastructure assets